Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

GYRE

Gyre Therapeutics (GYRE)

Gyre Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GYRE
DateTimeSourceHeadlineSymbolCompany
06/18/20243:05PMGlobeNewswire Inc.Gyre Therapeutics Announces Publication in Journal of Gastroenterology and HepatologyNASDAQ:GYREGyre Therapeutics Inc
06/17/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
05/30/20243:06PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GYREGyre Therapeutics Inc
05/30/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
05/30/20243:05PMGlobeNewswire Inc.Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial HypertensionNASDAQ:GYREGyre Therapeutics Inc
05/30/20243:02PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GYREGyre Therapeutics Inc
05/28/20243:05PMGlobeNewswire Inc.Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® IndexesNASDAQ:GYREGyre Therapeutics Inc
05/13/20243:07PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GYREGyre Therapeutics Inc
05/09/20243:10PMGlobeNewswire Inc.Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:GYREGyre Therapeutics Inc
05/09/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
05/08/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
03/26/20245:00AMGlobeNewswire Inc.Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:GYREGyre Therapeutics Inc
03/21/20246:00AMGlobeNewswire Inc.Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. NussbaumNASDAQ:GYREGyre Therapeutics Inc
12/15/20238:04AMPR Newswire (US)Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B FundingNASDAQ:GYREGyre Therapeutics Inc
11/13/20236:00AMGlobeNewswire Inc.Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver MeetingNASDAQ:GYREGyre Therapeutics Inc
11/02/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
11/01/20234:18PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GYREGyre Therapeutics Inc
11/01/20233:58PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GYREGyre Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GYRE

Your Recent History

Delayed Upgrade Clock